Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia - A single center experience on 160 patients

Bone Marrow Transplantation

Volumn 26, Issue 3, 2000, Pages 275-281

  Thiele, J ^a   Kvasnicka, H M ^a   Beelen, D W ^b   Zirbes, T K ^a   Jung, F ^a   Reske, D ^a   Leder, L D ^b   Schaefer, U W ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

BMT; CML; Hematopoietic reconstitution; IFN ; Morphometric quantification; Myelofibrosis

Indexed keywords

COLLAGEN; RETICULIN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 0033861582     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702505     Document Type: Article

References (42)

1. Rajantie J, Sale GE, Deeg HJ et al. Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. Blood 1986; 67: 1693-1697.
2. Smith JW, Shulman HM, Thomas ED et al. Bone marrow transplantation for acute myelosclerosis. Cancer 1981; 48: 2198-2203.
3. Wolf JL, Spruce WE, Bearman RM et al. Reversal of acute ('malignant') myelosclerosis by allogeneic bone marrow transplantation. Blood 1982; 59: 191-193.
4. Kroener JF, McMillan R, Beutler E. Acute myelofibrosis -treatment with allogeneic bone marrow transplantation. J Am Med Assoc 1983; 249: 1189-1190.
5. Bullorsky EO, Shanly CM, Stemmelin G et al. Acute megakaryoblastic leukemia with massive myelofibrosis: complete remission and reversal of marrow fibrosis with allogeneic bone marrow transplantation as the only treatment. Bone Marrow Transplant 1990; 6: 449-452.
6. De Revel T, Giraudier S, Nedellec G et al. Allogeneic bone marrow transplantation for postpolycythemic myeloid metaplasia with myelofibrosis: a case report. Bone Marrow Transplant 1995; 16: 187-189.
7. Singhal S, Powels R, Treleaven J et al. Allogeneic bone marrow transplantation for primary myelofibrosis. Bone Marrow Transplant 1995; 16: 743-746.
8. Anderson JE, Sale G, Appelbaum FR et al. Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythemia vera or essential thrombocytosis. Br J Haematol 1997; 98: 1010-1016.
9. Guardiola P, Esperou H, Cazales-Hatem C et al. Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. Br J Haematol 1997; 98: 1004-1009.
10. Przepiorka D, Giralt S, Khouri I et al. Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases. Am J Hematol 1998; 57: 24-28.
11. Guardiola P, Anderson JE, Bandini G et al for the International Collaboration for Transplantation in Agnogenic Myeloid Metaplasia. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Research Center Colloborative Study. Blood 1999; 93: 2831-2838.
12. Soll E, Massumoto C, Clift RA et al. Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment. Blood 1995; 86: 4667-4673.
13. Bauermeister DE. Quantitation of bone marrow reticulin: a normal range. Am J Clin Pathol 1971; 56: 24-31.
14. Straetmans N, Ma DDF, Nevell DF et al. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha Interferon and Ara-C therapy. Hematopathol Mol Hematol 1996; 10: 213-222.
15. Facchetti F, Tironi A, Marocolo D et al. Histopathological changes in bone marrow biopsies from patients with chronic myeloid leukaemia after treatment with recombinant alpha-interferon. Histopathol 1997; 31: 3-11.
16. Wilhelm M, Bueso-Ramos C, O'Brien S et al. Effect on interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia. Leukemia 1998; 12: 65-70.
17. McGlave PB, Brunning RD, Hurd DD et al. Reversal of severe bone marrow fibrosis and osteosclerosis following allogeneic bone marrow transplantation for chronic granulocytic leukaemia. Br J Haematol 1982; 52: 189-194.
18. Beelen DW, Graeven U, Elmaagacli AH et al. Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 1995; 36: 2981-2990.
19. Elmaagacli AH, Beelen DW, Schaefer UW. A retrospective single center study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 1045-1055.
20. Beelen DW, Elmaagacli AH, Schaefer UW. The adverse influence of pretransplant interferon-α (IFN-α) on transplant outcome after marrow transplantation for chronic phase chronic myelogenous leukemia increases with the duration of IFN-α exposure. Blood 1999; 93: 1779-1780.
21. Thiele J, Kvasnicka HM, Schmitt-Graeff A et al. Effects of interferon and hydroxyurea on hone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study. Br J Haematol 2000; 108: 64-71.
22. Lazzarino M, Morra E, Castello A et al. Myelofibrosis in chronic granulocytic leukemia. Clinical pathologic correlations and prognostic significance. Br J Haematol 1986; 64: 227-240.
23. Dekmezian R, Kantarjian HM, Keating M et al. The relevance of reticulin stain measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer 1987; 57: 1739-1743.
24. Buhr T, Choritz H, Georgii A. The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukemia. Virchows Arch A Pathol Anat 1992; 420: 473-478.
25. Georgii A, Buesche G, Kreft A. The histopathology of chronic myeloproliferative diseases. Baillières Clin Haematol 1998; 11: 721-724.
26. Thiele J, Kvasnicka HM, Schmitt-Graeff A et al. Bone marrow features and clinical findings in chronic myeloid leukemia - a comparative, multicenter, immunohistological and morphometric study on 614 patients. Leuk Lymphoma 2000; 36: 295-308.
27. Gratwohl A, Hermans J, Niederwieser D et al. for the Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Bone Marrow Transplant 1993; 12: 509-516.
28. Van Rhee F, Szydlo RM, Hermans J et al. for the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Long-term results after allogeneic bone marrow transplantation for chronic myelogeneous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997; 20: 553-560.
29. Savage DG, Szydlo RM, Chase A et al. Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse. Br J Haematol 1997; 99: 30-35.
30. Clift RA, Anasetti C, Allografting for chronic myeloid leukaemia. Baillière's Clin Haematol 1997; 10: 319-336.
31. Lamparelli T, Van Lint MT, Gualandi F et al. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Bone Marrow Transplant 1997; 20: 1057-1062.
32. Devergie A, Apperley JF, Labopin M et al. for the Chronic Leukemia Working Party of the European Group of Blood and Marrow Transplantation. European results of matched unrelated donor hone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Bone Marrow Transplant 1997; 20: 11-19.
33. Dini G, Lamparelli T, Rondelli R et al. Unrelated donor marrow transplantation for chronic myelogenous leukaemia. Br J Haematol 1998; 102: 544-552.
34. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. New Engl J Med 1998; 338: 962-968.
35. + myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components. Exp Hematol 1991; 19: 63-70.
36. Obinata M, Okuyama R, Matsuda KI et al. Regulation of myeloid and lymphoid development of hematopoietic stem cells by bone marrow stromal cells. Leuk Lymphoma 1998; 29: 61-69.
37. Dowding C, Gordon M, Guo AP et al. Potential mechanisms of action of interferon-alpha in CML. Leuk Lymphoma 1993; 11: 185-191.
38. Bhatia R, Wayner EA, McGlave PB et al. Interferon-α restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function. J Clin Invest 1994; 94: 384-391.
39. Verfaillie CM, Hurley R, Lundell BI et al. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underly the abnormal circulation and proliferation of CML progenitors? Acta Haematol 1997; 97: 40-52.
40. Bhatia R, Verfaille CM. The effect of interferon-α on beta-1-integrin mediated adhesion and growth regulation in chronic myelogenous leukemia. Leuk Lymphoma 1998; 28: 241-254.
41. Thiele J, Hoeppner B, Zankovich R et al. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/ sclerosis (agnogenic myeloid metaplasia) - correlations between clinical and morphological features. Virchows Arch A Pathol Anat Histol 1989; 415: 191-202.
42. Georgii A, Vykoupil KF, Buhr T et al. Chronic myeloproliferative disorders in bone marrow biopsies. Path Res Pract 1990; 186: 3-27.